haloperidol has been researched along with fauc 346 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boeckler, F; Gmeiner, P; Hocke, C; Hübner, H; Kuwert, T; Prante, O; Salama, I; Utz, W | 1 |
| Berardi, F; Contino, M; De Giorgio, P; Lacivita, E; Leopoldo, M; Perrone, R | 1 |
| Gmeiner, P; Hübner, H; Löber, S; Skultety, M | 1 |
3 other study(ies) available for haloperidol and fauc 346
| Article | Year |
|---|---|
Structure-selectivity investigations of D2-like receptor ligands by CoMFA and CoMSIA guiding the discovery of D3 selective PET radioligands.
Topics: Animals; Benzamides; Fluorine Radioisotopes; In Vitro Techniques; Ligands; Models, Molecular; Molecular Conformation; Piperazines; Positron-Emission Tomography; Quantitative Structure-Activity Relationship; Radioligand Assay; Radiopharmaceuticals; Receptors, Dopamine D2; Receptors, Dopamine D3; Swine | 2007 |
Design, synthesis, and binding affinities of potential positron emission tomography (PET) ligands with optimal lipophilicity for brain imaging of the dopamine D3 receptor. Part II.
Topics: Amides; Drug Design; Humans; Ligands; Piperazines; Positron-Emission Tomography; Protein Binding; Radiopharmaceuticals; Receptors, Dopamine D3 | 2009 |
Bioisosteric replacement leading to biologically active [2.2]paracyclophanes with altered binding profiles for aminergic G-protein-coupled receptors.
Topics: Animals; Binding, Competitive; Cell Line; Cricetinae; Cricetulus; Humans; In Vitro Techniques; Ligands; Models, Molecular; Mutation; Piperazines; Radioligand Assay; Receptors, Adrenergic, alpha-1; Receptors, Dopamine; Receptors, Serotonin; Structure-Activity Relationship; Swine; Thiophenes | 2010 |